How RadNet’s (RDNT) AI Reporting Tools Could Improve Imaging Center Scale and Workflow

RadNet, Inc. (NASDAQ:RDNT) is one of the best medical care facilities stocks to buy according to analysts. Analysts see about 30.6% average upside, and the company has fairly direct exposure to outpatient diagnostic facilities through its imaging center network. The most relevant recent development came on June 10, when DeepHealth, RadNet’s wholly owned subsidiary, launched Reporting Pro for commercial deployment.

The product brings speech recognition, AI-generated findings, measurements, impressions, quality assurance, and structured reporting into one workflow for radiology reporting. The news matters because imaging centers are not only a real-estate-and-scanner business anymore; throughput, reporting speed, quality control, and physician workflow all affect capacity and service levels.

How RadNet’s (RDNT) AI Reporting Tools Could Improve Imaging Center Scale and Workflow

RadNet has also been building around digital health, giving analysts a reason to view it as more than a traditional outpatient imaging operator. Still, the core tie to this list is simple: diagnostic imaging remains a major outpatient access point, and RadNet’s technology push is aimed at making that care model more scalable.

RadNet, Inc. (NASDAQ:RDNT) operates fixed-site outpatient diagnostic imaging centers and develops radiology digital health solutions.

While we acknowledge the risk and potential of RDNT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than RDNT and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1